http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2257896-C2
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192 |
| filingDate | 2003-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12f5c3743bbf585f24a3b9ec128d2df9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88bfe33da33fada808ad1af1097bd498 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75b737a5a91eeb6e596ba9adb750840b |
| publicationDate | 2005-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2257896-C2 |
| titleOfInvention | Method for anesthesia at short-term laser-surgical interferences in the field of ophthalmology |
| abstract | FIELD: medicine, ophthalmology. n SUBSTANCE: one should intramuscularly introduce Ketanov about 1 h before operation, not later, at the dosage of 0.4-0.45 mg/kg patient's body weight followed by local anesthetization as blockade of pterygopalatine ganglion and akinesia with 2%-lidocaine solution. The present innovation enables to prolong anesthetization in post-operational period that, in its turn, prevents iatrogenic complications, especially in senile patients. n EFFECT: higher efficiency. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2556792-C1 |
| priorityDate | 2003-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.